Between 2018 and 2023, Antiretroviral Therapy (ART) coverage in Japan for adult women living with HIV increased consistently, showing a year-on-year growth. By 2023, the coverage reached 100%. Over the last two years, the coverage rate improved by approximately 3% annually, with a cumulative average growth rate (CAGR) of 2.3% over the past five years.

Future trends to watch for include:

Continued efforts in public health policy to sustain or potentially exceed 100% coverage.
The impact of medical advancements and policy changes on maintaining comprehensive coverage.
Social and economic factors that may influence accessibility and adherence to ART.